Title:
APPLICATION OF ARTEMISININ COMPOUNDS IN PROMOTING CHIMERIC ANTIGEN RECEPTOR T CELL TREATMENT, AND PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2020/207257
Kind Code:
A1
Abstract:
Provided in the present invention is an application of artemisinin compounds in the preparation of formulations that promote chimeric antigen receptor T cell treatment of malignant tumours, autoimmune disease, or AIDS, and also provided is a pharmaceutical composition used for the treatment of malignant tumours, autoimmune disease, or AIDS, comprising chimeric antigen receptor T cells and artemisinin compounds.
Inventors:
LIU MAOXUAN (CN)
XU CHENGUANG (CN)
TANG CHAO (CN)
WEN LILIAN (CN)
XU CHENGUANG (CN)
TANG CHAO (CN)
WEN LILIAN (CN)
Application Number:
PCT/CN2020/081343
Publication Date:
October 15, 2020
Filing Date:
March 26, 2020
Export Citation:
Assignee:
SHENZHEN BINDEBIOTECH CO LTD (CN)
International Classes:
A61K31/357; A61K39/00; A61P35/00; C07K19/00
Foreign References:
| CN109453156A | 2019-03-12 | |||
| CN109453156A | 2019-03-12 |
Other References:
孙祖俊等 (SUN, ZUJUN ET AL.): "嵌合抗原受体修饰T细胞治疗实体肿瘤研究进展 (Progress of Study on Chimeric Antigen Receptor T Cells in the Treatment of Solid Tumors)", 肿瘤预防与治疗 (JOURNAL OF CANCER CONTROL AND TREATMENT), vol. 31, no. 4, 31 August 2018 (2018-08-31), XP55742086, DOI: 20200620200025Y
Attorney, Agent or Firm:
SCIHEAD IP LAW FIRM (CN)
Download PDF: